Performance vs S&P 500

03
Tracked Q2 2025–Q4 2025 +29.4%
S&P 500 total return (same window) +11.9%
Excess return +17.4%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 15.4%

Sector breakdown

04
Healthcare 89.8%
Consumer Discretionary 0.7%
Industrials 0.0%
Other/Unmapped 9.5%

Full portfolio 22 positions

05
Type Streak 8Q trend
WGS GeneDx Holdings Corp. - Class A Common Stock $115,058,099 68.51% 884,654 $19,174,455 Down ×4
ARDX Ardelyx, Inc. - Common Stock $10,917,398 6.50% 1,872,624 $2,631,317 Up ×2
BHVN Biohaven Ltd. Common Shares $8,717,923 5.19% 772,181 $-2,389,267 Up ×3
Unknown issuer (CUSIP: 87918A905) $4,550,000 2.71% 650,000 Call option $913,035 Up ×1
Unknown issuer (CUSIP: 670002AD6) $4,032,000 2.40% 600,000 Call option Up ×1
Unknown issuer (CUSIP: 039697907) $3,498,000 2.08% 600,000 Call option $11,272 Down ×2
QDEL QuidelOrtho Corporation - Common Stock $3,378,391 2.01% 118,291 $-105,279
FORA Forian Inc. - Common Stock $2,896,147 1.72% 1,366,107 $-177,594
PSNL Personalis, Inc. - Common Stock $2,701,170 1.61% 339,343 $1,205,254 Up ×1
Unknown issuer (CUSIP: G1110E907) $2,629,441 1.57% 232,900 Call option $-1,498,309 Down ×1
TDOC Teladoc Health, Inc. Common Stock $2,480,366 1.48% 354,338 $-2,972,500 Down ×1
TSHA Taysha Gene Therapies, Inc. - Common Stock $1,457,500 0.87% 265,000 Up ×1
CAVA CAVA Group, Inc. Common Stock $1,003,599 0.60% 17,100 $-29,412
EWTX Edgewise Therapeutics, Inc. - Common Stock $951,482 0.57% 38,343 Up ×1
DAWN Day One Biopharmaceuticals, Inc. - Common Stock $932,000 0.55% 100,000 Up ×1
Unknown issuer (CUSIP: 717081903) $622,500 0.37% 25,000 Call option Up ×1
ARKG ARK ETF Trust $564,915 0.34% 19,500 Up ×1
SGMO Sangamo Therapeutics, Inc. - Common Stock $435,012 0.26% 1,035,742 $-241,569 Up ×1
BIIB Biogen Inc. - Common Stock $424,488 0.25% 2,412 $86,615
TEM Tempus AI, Inc. - Class A Common Stock $384,238 0.23% 6,507 Up ×1
TSLA Tesla, Inc. - Common Stock $224,860 0.13% 500 $2,500
HTZ Hertz Global Holdings, Inc - Common Stock $77,100 0.05% 15,000 Up ×1

Conviction holdings

08

Positions increased for 3+ consecutive quarters.

Share counts are as reported in 13F filings (not split-adjusted)

SecurityValue% of portfolioStreak
BHVN $8,717,923 5.19% up ×3

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
Unknown issuer (CUSIP: 670002AD6) $4,032,000 600,000 2.40%
TSHA $1,457,500 265,000 0.87%
EWTX $951,482 38,343 0.57%
DAWN $932,000 100,000 0.55%
Unknown issuer (CUSIP: 717081903) $622,500 25,000 0.37%
ARKG $564,915 19,500 0.34%
TEM $384,238 6,507 0.23%
HTZ $77,100 15,000 0.05%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
WGS Trimmed -5K +$19.2M
TDOC Trimmed -351K -$3.0M
ARDX Bought more +369K +$2.6M
BHVN Bought more +32K -$2.4M
· Trimmed -42K -$1.5M
PSNL Bought more +110K +$1.2M
· Bought more +180K +$913K
SGMO Bought more +31K -$242K
FORA Price move only +0 -$178K
QDEL Price move only +0 -$105K

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
SWTX June 30, 2025 531,351 $23,448,520 No longer tracked
PLTR Dec. 31, 2025 29,500 $5,381,390 10.7%
CNC Dec. 31, 2025 110,300 $3,935,504 70.5%
NVAX Dec. 31, 2025 243,000 $2,106,810 44.3%
KOID Dec. 31, 2025 22,400 $718,592
RXRX June 30, 2025 120,000 $634,800 -26.9%
BDSX Dec. 31, 2025 15,000 $113,250 211.5%